Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.
Management of atrial fibrillation / Vergara, P; Della Bella, P.. - In: F1000 PRIME REPORTS. - ISSN 2051-7599. - 6:(2014), p. 22. [10.12703/P6-22]
Management of atrial fibrillation
VERGARA P;
2014
Abstract
Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.| File | Dimensione | Formato | |
|---|---|---|---|
|
28_Vergara_AF_F1000.pdf
non disponibili
Licenza:
Non specificato
Dimensione
652.87 kB
Formato
Adobe PDF
|
652.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
